文献速递新生儿

极早产儿光疗期间避光皮肤经皮胆红素测定的可靠性

Patched Skin Bilirubin Assay to Monitor Neonates Born Extremely Preterm Undergoing Phototherapy.
PubMed 文献 · J Pediatr · 2017-06-26

结果显示TcB与TSB显著相关(r=0.84;P<.001),但TcB在高值处高估TSB(平均差异TSB-TcB:-2.8[2.4] mg/dL),若仅用TcB决策,无患儿被过早停止光疗,但21例(35%)本可停止光疗却继续治疗。

要点

  • 避光皮肤TcB与TSB显著相关(r=0.84;P<.001),校正血红蛋白、pH、乳酸、胎龄、日龄或治疗时长后仍相关。
  • TcB在高胆红素值处高估TSB(平均差异TSB-TcB:-2.8[2.4] mg/dL)。
  • 仅用TcB决策不会导致光疗过早停止,但可能使21例(35%)本可停止光疗者继续治疗。

核心结论

  • 极早产儿光疗期间避光皮肤TcB与TSB的相关性与更成熟新生儿相当,且不受临床变量或影响皮肤胆红素通过的因素影响。
  • TcB高估TSB,可能使极早产儿接受不必要的光疗,但可减少约65%的TSB测定。

研究设计与样本

  • TcB测定后10分钟内测定TSB、乳酸、pH、血红蛋白和皮肤温度;临床医生对TcB值设盲,仅根据TSB决定光疗。

主要发现

  • TcB与TSB显著相关(r=0.84;P<.001)。
  • 校正血红蛋白、pH、乳酸、胎龄和日龄后,TcB与TSB仍显著相关(标准化β=0.8;P<.001;校正R2=0.75)。
  • 校正治疗时长后,TcB与TSB仍显著相关(标准化β=0.8;P<.001;校正R2=0.7)。
  • Bland-Altman分析显示TcB在高值处高估TSB(平均差异TSB-TcB:-2.8[2.4] mg/dL)。
  • 若仅用TcB决策,无新生儿被过早停止光疗,但21例(35%)本可停止光疗却继续治疗。

临床怎么用

  • 在极早产儿光疗期间,可考虑在避光皮肤区域使用TcB监测胆红素,以减少TSB采血次数。
  • 需注意TcB在高值处高估TSB,仅凭TcB决策可能导致不必要的光疗延长,应结合临床和TSB综合判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To verify the reliability and safety of transcutaneous bilirubin (TcB) measurements in patched skin areas in neonates born extremely preterm under phototherapy. STUDY DESIGN: Sixty neonates (<30 weeks' gestation) receiving phototherapy were enrolled and TcB was measured via a second-generation transcutaneous bilirubinometer in patched skin areas (of at least 2.5 cm diameter). Total serum bilirubin (TSB), lactate, pH, hemoglobin, and skin temperature were measured within 10 minutes of the TcB assay. Clinicians were blinded to TcB values, and clinical decisions about phototherapy were made with the TSB measurement only. RESULTS: TcB and TSB significantly were correlated (r = 0.84; P <.001), even after adjustment for hemoglobin, pH, lactate, gestational and postnatal age (standardized β = 0.8; P <.001; adjusted R2 = 0.75), or treatment duration (standardized β = 0.8; P <.001; adjusted R2 = 0.7). When the Bland-Altman analysis was used, TcB overestimated TSB at high values (mean difference TSB - TcB: -2.8 [2.4] mg/dL). If clinicians used the TcB only, no neonate would have had phototherapy stopped prematurely, and 21 (35%) would have continued phototherapy when it could have been stopped. CONCLUSIONS: The correlation between TSB and TcB (measured in patched skin areas) was comparable with that obtained in more mature neonates, and it was not influenced by clinical variables or factors affecting skin bilirubin passage. TcB overestimated TSB, and this may expose infants born preterm to unnecessary phototherapy, although it could spare approximately 65% of TSB assays.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. De Luca D, Dell'Orto V. Patched Skin Bilirubin Assay to Monitor Neonates Born Extremely Preterm Undergoing Phototherapy. J Pediatr. 2017. PMID: 28662949. doi:10.1016/j.jpeds.2017.05.080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。